Equity-backed commitment dramatically de-risks pivotal program, boosts licensing appeal, and strengthens commercialization readiness. HUNTINGTON, N.Y., Dec. 11, 2025 /PRNewswire/ -- Sen-Jam ...
Conduit Pharmaceuticals Inc. has announced a strategic services agreement with Agility Life Sciences to develop new solid oral-dosage form products for its autoimmune pipeline, intended for future ...
13-Week Study to Evaluate the Safety and Efficacy of Oral VK2735 Dosed Once Daily SAN DIEGO, Jan. 8, 2025 /PRNewswire/ -- Viking Therapeutics, Inc. (VKTX), a clinical-stage biopharmaceutical company ...
Phase two of the stakeholder engagement program, includes active consultation with government entities and the health sector. Phase two to begin on September 16. United Arab Emirates, Dubai, September ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback